Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (19)

2024

  1. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

  2. Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study

    International Journal of Cardiology, Vol. 413

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580

2022

  1. Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 1, pp. 60-66

2021

  1. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926

2018

  1. A Novel Heterozygous Intronic Mutation in the FBN1 Gene Contributes to FBN1 RNA Missplicing Events in the Marfan Syndrome

    BioMed Research International, Vol. 2018

  2. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57

  3. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

  2. Impact of clinical profile of donor, recipient, and ischemia time on survival of heart transplant patients. Subanalysis of the Spanish Heart Transplantation Registry

    Cirugia Cardiovascular, Vol. 22, Núm. 6, pp. 279-286

2014

  1. Antibody-mediated rejection: Analyzing the risk, proposing solutions

    Transplantation, Vol. 98, Núm. SUPPL. 3

  2. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients

    Transplantation Reviews, Vol. 28, Núm. 2, pp. 84-91

2012

  1. Development and validation of a specific questionnaire for evaluating the impact of gastrointestinal symptoms on the health-related quality of life of transplant patients

    Transplantation Proceedings, Vol. 44, Núm. 5, pp. 1281-1286

  2. New concepts and best practices for management of pre- and post-transplantation cancer

    Transplantation Reviews, Vol. 26, Núm. 4, pp. 261-279

  3. Transplantation for complex congenital heart disease in adults: A subanalysis of the Spanish Heart Transplant Registry

    Clinical Transplantation, Vol. 26, Núm. 5, pp. 755-763

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

2003

  1. Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit

    Infection Control and Hospital Epidemiology, Vol. 24, Núm. 3, pp. 207-213